期刊文献+

全胸腔镜下肺叶切除术与常规开胸肺叶切除术治疗肺癌的效果比较 被引量:9

Comparison of the effect of total thoracoscopic lobectomy versus conventional thoracotomy in treatment of lung cancer
原文传递
导出
摘要 目的:比较肺癌患者采用全胸腔镜下肺叶切除术和常规开胸肺叶切除术治疗的临床效果。方法:抽取2015年1月至2016年11月滨州医学院附属医院收治的82例的肺癌患者的临床资料,根据手术方式不同将其分为对照组和观察组,每组41例。对照组患者行常规开胸肺叶切除术,观察组患者行全胸腔镜下肺叶切除术。比较两组患者手术相关指标、术后免疫功能指标、远期生存情况(局部复发、远处转移、1年生存、3年生存)。结果:观察组手术时间、置管引流时间、下床活动时间、疼痛持续时间均短于对照组,术后引流量少于对照组,淋巴清扫量多于对照组,术后视觉模拟评分法(VAS)评分低于对照组,差异均有统计学意义(P均<0.05);术后3、6个月,两组CD4+、CD8+、CD4+/CD8+指标均下降,且观察组均高于对照组,差异均有统计学意义(P均<0.05);观察组局部复发率、远处转移率略低于对照组,1年生存率及3年生存率略高于对照组,但差异未见统计学意义(P>0.05)。结论:肺癌患者给予全胸腔镜下肺叶切除术能够促进患者术后恢复,提高术后免疫功能,与常规手术相比,可在一定程度上降低复发率,提高远期生存率。 Objective To compare the effect of total thoracoscopic lobectomy and conventional thoracotomy lobectomy in treatment of lung cancer.Methods The clinical data of 82 patients with lung cancer admitted to Binzhou Medical College Affiliated Hospital from January 2015 to November 2016 were retrospectively collected.According to different surgical methods,the patients were divided into control group and observation group,with 41 patients in each group.Patients in the control group received conventional thoracotomy lobectomy,and patients in the observation group received total thoracoscopic lobectomy.The indexes related to surgery,postoperative immune function and long-term survival(local recurrence,distant metastasis,1-year survival and 3-year survival)were compared between the two groups.Results The operative time,catheter drainage time,normal activity time and duration of pain in the observation group were all shorter than that in the control group.The postoperative drainage volume was less than that in the control group,the amount of lymph node dissection was more than that in the control group,and the postoperative VAS score was lower than that in the control group,with statistically significant differences(all P<0.05).Three and six months after operation,CD4+,CD8+,CD4+/CD8+indexes in both groups decreased,and those in the observation group were higher than those in the control group,with statistically significant differences(all P<0.05).The local recurrence rate and distant metastasis rate in the observation group were slightly lower than those in the control group,and the 1-year and 3-year survival rates were slightly higher than those in the control group,but the differences were not statistically significant(P>0.05).Conclusions Total thoracoscopic lobectomy for patients with lung cancer can promote postoperative recovery and improve postoperative immune function.Compared with conventional surgery,it can reduce recurrence rate to a certain extent and improve long-term survival rate.
作者 杨磊 陈晓军 于健 刘超 宋杨杨 张金贵 Yang Lei;Chen Xiaojun;Yu Jian;Liu Chao;Song Yangyang;Zhang Jingui(Department of Thoracic Surgery,Binzhou Medical College Affiliated Hospital,Binzhou Central Hospital,Binzhou 251700,China)
出处 《中国实用医刊》 2020年第14期78-81,共4页 Chinese Journal of Practical Medicine
关键词 肺癌 全胸腔镜下肺叶切除术 术后康复 Lung cancer Complete thoracoscopic lobectomy Postoperative rehabilitation
  • 相关文献

参考文献14

二级参考文献133

  • 1Ettinger DS, Bepler G, Bueno R, et al. Non-small cell lung can- cer clinical practice guidelines in oncalogy [J]. J Natl Compr Canc Netw, 2006,4(6): 548-582.
  • 2Shaw JP, Dembitzer FR,Wisnivesky JP,et al. Video-assisted thoraco- spic lobectomy:state of the art and future directiona [J]. Ann Tho- rac Surg,2008,85(2):705-709.
  • 3Whitson BA, Groth SS, Duval SJ, et al. Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assist-ed thoracoscopic surgery versus thoracotomy approaches to lobecto- my [J]. Ann Thorac Surg, 2008,86(6) : 2008-2016.
  • 4Flores RM, Park BJ, Dycoco J, et al. Lobectomy by video-assist- ed thoracic surgery (VATS) versus thoracotomy for lung cancer [J]. J Thorac Cardiovasc Surg, 2009,138(1) : 11-18.
  • 5Kohno T. Lobectomy and systematic lymphnode dissection for pri- mary lung cancer by video-assisted thoracic surgery(VATS) [J]. Nippon Geka Gakkai Zasshi, 2008,109(5) : 285-290.
  • 6范兴龙.电视胸腔镜手术治疗早期非小细胞肺癌的临床研究及预后分析.山东大学学报,2013,51:173-175.
  • 7Hyun Jin Cho,Sung Ryong Kim,Hyeong Ryul Kim,Jin-Ok Han,Yong-Hee Kim,Dong Kwan Kim,Seung-Il Park.Modern Outcome and Risk Analysis of Surgically Resected Occult N2 Non-Small Cell Lung Cancer[J]. The Annals of Thoracic Surgery . 2014 (6)
  • 8Marc Riquet,Antoine Legras,Pierre Mordant,Caroline Rivera,Alex Arame,Laure Gibault,Christophe Foucault,Antoine Dujon,Fran?oise Le Pimpec Barthes.Number of Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer: A Gaussian Curve, Not a Prognostic Factor[J]. The Annals of Thoracic Surgery . 2014
  • 9Wei-Yu Liao,Jin-Hsin Chen,Muzo Wu,Jin-Yuan Shih,Kuan-Yuh Chen,Chao-Chi Ho,James Chih-Hsin Yang,Chong-Jen Yu.Neoadjuvant Chemotherapy With Docetaxel-Cisplatin in Patients With Stage III N2 Non–Small-Cell Lung Cancer[J]. Clinical Lung Cancer . 2013 (4)
  • 10Jin Hyun Park,Tae Min Kim,Bhumsuk Keam,Yoon Kyung Jeon,Se-Hoon Lee,Dong-Wan Kim,Doo Hyun Chung,Young Tae Kim,Young Whan Kim,Dae Seog Heo.Tumor Burden is Predictive of Survival in Patients With Non–Small-Cell Lung Cancer and With Activating Epidermal Growth Factor Receptor Mutations Who Receive Gefitinib[J]. Clinical Lung Cancer . 2013 (4)

共引文献211

同被引文献116

引证文献9

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部